A Study of RC118 in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors

NCT05205850 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: RC118-ADC

Sponsor

RemeGen Co., Ltd.